These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 32333068

  • 1. Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients.
    Bruckmann NM, Sawicki LM, Kirchner J, Martin O, Umutlu L, Herrmann K, Fendler W, Bittner AK, Hoffmann O, Mohrmann S, Dietzel F, Ingenwerth M, Schaarschmidt BM, Li Y, Kowall B, Stang A, Antoch G, Buchbender C.
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2816-2825. PubMed ID: 32333068
    [Abstract] [Full Text] [Related]

  • 2. Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
    Bruckmann NM, Kirchner J, Morawitz J, Umutlu L, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Ingenwerth M, Schaarschmidt BM, Li Y, Stang A, Antoch G, Sawicki LM, Buchbender C.
    PLoS One; 2021 Nov; 16(12):e0260804. PubMed ID: 34855886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients.
    Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Antke C, Schimmöller L, Ingenwerth M, Breuckmann K, Stang A, Buchbender C, Antoch G, Sawicki LM.
    Eur Radiol; 2021 Nov; 31(11):8714-8724. PubMed ID: 33912991
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
    Taneja S, Jena A, Goel R, Sarin R, Kaul S.
    Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.
    Heusch P, Nensa F, Schaarschmidt B, Sivanesapillai R, Beiderwellen K, Gomez B, Köhler J, Reis H, Ruhlmann V, Buchbender C.
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):42-8. PubMed ID: 25112399
    [Abstract] [Full Text] [Related]

  • 9. Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI.
    Kirchner J, Grueneisen J, Martin O, Oehmigen M, Quick HH, Bittner AK, Hoffmann O, Ingenwerth M, Catalano OA, Heusch P, Buchbender C, Forsting M, Antoch G, Herrmann K, Umutlu L.
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2328-2337. PubMed ID: 30056547
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 18F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.
    Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L.
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):622-629. PubMed ID: 29164299
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.
    Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, Bockisch A, Forsting M, Lauenstein T, Antoch G, Stahl A.
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1077-86. PubMed ID: 20204355
    [Abstract] [Full Text] [Related]

  • 12. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A, Kumar VS, Shamim SA, Gamanagatti S, Khan SA.
    Clin Orthop Relat Res; 2021 Aug 01; 479(8):1768-1779. PubMed ID: 33635285
    [Abstract] [Full Text] [Related]

  • 13. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
    Vaarwerk B, Breunis WB, Haveman LM, de Keizer B, Jehanno N, Borgwardt L, van Rijn RR, van den Berg H, Cohen JF, van Dalen EC, Merks JH.
    Cochrane Database Syst Rev; 2021 Nov 09; 11(11):CD012325. PubMed ID: 34753195
    [Abstract] [Full Text] [Related]

  • 14. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb 09; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 15. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 09; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 16. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Botsikas D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, Boudabbous S, Montet X, Lam GT, Mainta I, Kalovidouri A, Becker M.
    Eur Radiol; 2019 Apr 09; 29(4):1787-1798. PubMed ID: 30267154
    [Abstract] [Full Text] [Related]

  • 17. Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer.
    Kirchner J, Sawicki LM, Nensa F, Schaarschmidt BM, Reis H, Ingenwerth M, Bogner S, Aigner C, Buchbender C, Umutlu L, Antoch G, Herrmann K, Heusch P.
    Eur J Nucl Med Mol Imaging; 2019 Feb 09; 46(2):437-445. PubMed ID: 30074073
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.
    J Nucl Med; 2008 Aug 09; 49(8):1215-22. PubMed ID: 18632831
    [Abstract] [Full Text] [Related]

  • 19. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P, Buchbender C, Köhler J, Nensa F, Gauler T, Gomez B, Reis H, Stamatis G, Kühl H, Hartung V, Heusner TA.
    J Nucl Med; 2014 Mar 09; 55(3):373-8. PubMed ID: 24504054
    [Abstract] [Full Text] [Related]

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Mar 09; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.